Chesed Abraham's Form 4 filing
Turn Therapeutics Inc. (TTRX) · filed Oct 29, 2025
- Accession no.
- 0001104659-25-103894
- Filed
- Oct 29, 2025
- Trade date
- Oct 23, 2025
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $65.7K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chesed AbrahamCIK 0002094374 | Other: Board Observer |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | Common Stock | PPurchaseAcquired | +14,286 | $4.60 | +$65,715.6 | 1,447,268 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.